Peili Wu

559 total citations
27 papers, 390 citations indexed

About

Peili Wu is a scholar working on Reproductive Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Peili Wu has authored 27 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Reproductive Medicine, 7 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Peili Wu's work include Endometriosis Research and Treatment (9 papers), Reproductive System and Pregnancy (6 papers) and Endometrial and Cervical Cancer Treatments (5 papers). Peili Wu is often cited by papers focused on Endometriosis Research and Treatment (9 papers), Reproductive System and Pregnancy (6 papers) and Endometrial and Cervical Cancer Treatments (5 papers). Peili Wu collaborates with scholars based in China and United States. Peili Wu's co-authors include Hong Chen, Jia Sun, Weiheng Wen, Cheng Zeng, Jitong Li, Qing Xue, Min Zhao, Tze‐chen Hsieh, Jie Xu and Joseph Wu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes and Biology of Reproduction.

In The Last Decade

Peili Wu

25 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peili Wu China	10	130	91	67	64	54	27	390
Ye Huang China	12	147 1.1×	35 0.4×	31 0.5×	84 1.3×	30 0.6×	38	395
Surajeet Kumar Patra India	11	63 0.5×	54 0.6×	68 1.0×	42 0.7×	67 1.2×	24	383
Xiaoyan Yang China	14	137 1.1×	28 0.3×	116 1.7×	53 0.8×	17 0.3×	42	545
Shinobu Sakamoto Japan	13	109 0.8×	37 0.4×	63 0.9×	47 0.7×	22 0.4×	37	388
Yıldız Öner-İyidoğan Türkiye	14	61 0.5×	38 0.4×	46 0.7×	55 0.9×	126 2.3×	21	392
J Martínek Czechia	13	123 0.9×	48 0.5×	50 0.7×	45 0.7×	75 1.4×	53	434
Jean‐Marc Lobaccaro France	10	184 1.4×	99 1.1×	72 1.1×	23 0.4×	41 0.8×	12	449
Sabahattin Aslan Türkiye	12	116 0.9×	87 1.0×	41 0.6×	16 0.3×	29 0.5×	17	425
Dalia A. Elgamal Egypt	11	72 0.6×	29 0.3×	58 0.9×	21 0.3×	22 0.4×	23	311
Kaixuan Yan China	12	117 0.9×	65 0.7×	12 0.2×	39 0.6×	54 1.0×	28	453

Countries citing papers authored by Peili Wu

Since Specialization

Citations

This map shows the geographic impact of Peili Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peili Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peili Wu more than expected).

Fields of papers citing papers by Peili Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peili Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peili Wu. The network helps show where Peili Wu may publish in the future.

Co-authorship network of co-authors of Peili Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Peili Wu. A scholar is included among the top collaborators of Peili Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peili Wu. Peili Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guo, Lei, Peili Wu, Qing Li, et al.. (2025). NUAK1 Promotes Diabetic Kidney Disease by Accelerating Renal Tubular Senescence via the ROS/P53 Axis. Diabetes. 74(12). 2405–2417.

Li, Xuelin, Min Luo, Yanmei Zeng, et al.. (2025). MicroRNA-24-3p targeting Top1 in perirenal fat is involved in circulating inflammation and high cardiovascular disease risk in patients with primary aldosteronism. Journal of Translational Medicine. 23(1). 345–345. 2 indexed citations

Wu, Peili, Yan Zhang, Jun Chen, et al.. (2024). Radiological biomarkers reflecting visceral fat distribution help distinguish inflammatory bowel disease subtypes: a multicenter cross-sectional study. Insights into Imaging. 15(1). 70–70. 3 indexed citations

Zhang, Yan, Peili Wu, Jun Chen, et al.. (2024). Enhancing radiologist's detection: an imaging-based grading system for differentiating Crohn's disease from ulcerative colitis. BMC Medicine. 22(1). 441–441. 2 indexed citations

Li, Fangyuan, Jinchen Liu, Yongyan Hu, et al.. (2024). Targeting Estrogen Receptor Beta Ameliorates Diminished Ovarian Reserve via Suppression of the FOXO3a/Autophagy Pathway. Aging and Disease. 9 indexed citations

Xu, Zijin, et al.. (2023). MicroRNA-92a-3p Inhibits Cell Proliferation and Invasion by Regulating the Transcription Factor 21/Steroidogenic Factor 1 Axis in Endometriosis. Reproductive Sciences. 30(7). 2188–2197. 7 indexed citations

Wu, Peili, et al.. (2023). The PES1/FOXM1 heterodimer suppresses TCF21 and ERβ expression in ovarian endometriosis. SHILAP Revista de lepidopterología. 5(1).

Wu, Peili, et al.. (2022). IGFBP7 enhances trophoblast invasion via IGF-1R/c-Jun signaling in unexplained recurrent spontaneous abortion. Reproduction. 164(5). 231–241. 12 indexed citations

Wu, Peili, et al.. (2021). Increased SUMOylation of TCF21 improves its stability and function in human endometriotic stromal cells. Biology of Reproduction. 105(1). 128–136. 6 indexed citations

10.

Wu, Peili, et al.. (2021). Clinical and X-ray characteristics for expressions of different receptors in patients with breast cancer.. PubMed. 46(3). 263–271. 1 indexed citations

11.

Wang, Xiaoqing, Peili Wu, Xin Li, et al.. (2021). Extracellular Vesicles Inhibit Proliferation and Invasion of Ovarian Endometrial Stromal Cells and Their Expression of SF-1, ERβ, and Aromatase. Frontiers in Endocrinology. 12. 666195–666195. 5 indexed citations

12.

Wen, Weiheng, et al.. (2021). Comprehensive Analysis of NAFLD and the Therapeutic Target Identified. Frontiers in Cell and Developmental Biology. 9. 704704–704704. 26 indexed citations

13.

Zeng, Cheng, et al.. (2020). YAP1 inhibits ovarian endometriosis stromal cell invasion through ESR2. Reproduction. 160(3). 481–490. 5 indexed citations

14.

Zeng, Cheng, Jing Shang, Aoming Jin, et al.. (2019). The effect of luteal GnRH antagonist on moderate and severe early ovarian hyperstimulation syndrome during in vitro fertilization treatment: a prospective cohort study. Archives of Gynecology and Obstetrics. 300(1). 223–233. 14 indexed citations

15.

Wu, Peili, Weiheng Wen, Jitong Li, et al.. (2019). Systematic Review and Meta-Analysis of Randomized Controlled Trials on the Effect of SGLT2 Inhibitor on Blood Leptin and Adiponectin Level in Patients with Type 2 Diabetes. Hormone and Metabolic Research. 51(8). 487–494. 88 indexed citations

16.

Wen, Weiheng, Peili Wu, Min Zhao, et al.. (2018). Association of Pioglitazone with Increased Risk of Prostate Cancer and Pancreatic Cancer: A Functional Network Study. Diabetes Therapy. 9(6). 2229–2243. 8 indexed citations

17.

Wen, Weiheng, Peili Wu, Jitong Li, et al.. (2018). Predictive values of the selected inflammatory index in elderly patients with papillary thyroid cancer. Journal of Translational Medicine. 16(1). 261–261. 28 indexed citations

18.

Wen, Weiheng, Peili Wu, Min Zhao, et al.. (2018). Mutations in gliclazide‐associated genes may predict poor bladder cancer prognosis. FEBS Open Bio. 9(3). 457–467. 6 indexed citations

19.

Zhou, Yan, Cheng Zeng, Xin Li, et al.. (2016). IGF-I stimulates ERβ and aromatase expression via IGF1R/PI3K/AKT-mediated transcriptional activation in endometriosis. Journal of Molecular Medicine. 94(8). 887–897. 39 indexed citations

20.

Hsieh, Tze‐chen, Peili Wu, Spencer Park, & Joseph Wu. (2006). Induction of cell cycle changes and modulation of apoptogenic/anti-apoptotic and extracellular signaling regulatory protein expression by water extracts of I'm-Yunity™ (PSP). BMC Complementary and Alternative Medicine. 6(1). 30–30. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact